Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Lyfebulb
AddedFeb 15, 2024
UpdatedJun 28, 2026
Lyfebulb

Lyfebulb

Lyfebulb: Accelerating innovation for chronic disease patients, bridging them with industry.

HQ
New York City, NY, US
Founded
2014
Overview
Compare
Employees
Website

Lyfebulb is dedicated to accelerating innovation for chronic disease patients by bridging patient communities with industry. The organization focuses on providing a strong voice to individuals living with chronic diseases, recognizing that patients and their care partners are uniquely positioned to offer valuable insights and solutions. Founded by Dr. Karin Hehenberger, Lyfebulb offers programs such as the Entrepreneur Circle and Ambassador initiatives to foster community engagement and collaboration.

Lyfebulb has made significant strides in connecting patients with industry leaders, driving innovation in chronic disease management. The organization has successfully created platforms for patient-driven insights and solutions, enhancing the quality of life for those affected by chronic illnesses. Through its various initiatives, Lyfebulb has established itself as a key player in the healthcare innovation space, making a tangible impact on the lives of chronic disease patients worldwide.

Lyfebulb - Similar Companies

Inspire logo

Inspire

inspire.com

LifePod Solutions logo

LifePod Solutions

lifepod.com

Lifeforce logo

Lifeforce

mylifeforce.com

Liyfe logo

Liyfe

Redi.Health logo

Redi.Health

redi.health

Belong.Life logo

Belong.Life

belong.life

Roon logo

Roon

LifeX logo

LifeX

lifex-labs.com

Jlabs logo

Jlabs

EIT Health logo

EIT Health

eithealth.eu

Afoundria logo

Afoundria

Oxygen4Life logo

Oxygen4Life

oxygen4life.com

SoCap Accelerate logo

SoCap Accelerate

Cecelia Health logo

Cecelia Health

ceceliahealth.com

AsepsisLife logo

AsepsisLife

Lyfebulb - Quick Facts

Who are Lyfebulb's competitors?

Companies similar to Lyfebulb include Inspire, LifePod Solutions, Lifeforce and Liyfe.

When was Lyfebulb founded?

Lyfebulb was founded in 2014.

Where is Lyfebulb's headquarters located?

Lyfebulb's headquarters is located in New York City, NY, US.

How many employees does Lyfebulb have?

Lyfebulb has 27 employees as of Feb 4, 2024.

Lyfebulb - Classification

Ownership
  • Private
Technology
  • Community
Geographic Exposure
  • Global
Customer
  • Consumers
  • Enterprise
  • Non-Profit
Main Product
  • Patient Support
Tags
  • Consulting
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 621000Ambulatory Health Care Services
  • 621400Outpatient Care Centers
  • 621490Other Outpatient Care Centers
  • 621491HMO Medical Centers
SIC
  • 8010Offices And Clinics Of Doctors Of Medicine
  • 8011Offices And Clinics Of Doctors Of Medicine